UBS lowered its price target for HCA Holdings (NYSE:HCA) to $36 from $40 and maintained its buy rating on the stock.
UBS has a potential upside of 37.6% based on a current price of $16.72 and an average consensus analyst price target of $23.
UBS is currently below its 50-day moving average (MA) of $17.98 and below its 200-day MA of $17.92.
